Invention Grant
US08389497B2 Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammals
有权
使用烷基磷酰胆碱与抗肿瘤药物联合用于治疗人类和哺乳动物的良性和恶性肿瘤
- Patent Title: Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammals
- Patent Title (中): 使用烷基磷酰胆碱与抗肿瘤药物联合用于治疗人类和哺乳动物的良性和恶性肿瘤
-
Application No.: US10632187Application Date: 2003-07-30
-
Publication No.: US08389497B2Publication Date: 2013-03-05
- Inventor: Jürgen Engel , Eckhard Günther , Herbert Sindermann
- Applicant: Jürgen Engel , Eckhard Günther , Herbert Sindermann
- Applicant Address: DE Frankfurt
- Assignee: AEterna Zentaris GmbH
- Current Assignee: AEterna Zentaris GmbH
- Current Assignee Address: DE Frankfurt
- Agency: Goodwin Procter LLP
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A61K31/685
Abstract:
The invention relates to the use of alkylphosphocholines in combination with antitumor medicaments for the treatment of benign and malignant oncoses in humans and animals. It is possible in this connection for the alkylphosphocholines to be employed in a combination according to the invention with one or a combination of various approved cytostatics. Preferred alkylphosphocholines are described by the Formula II.
Public/Granted literature
Information query
